Awards/COOPERATIVE AGREEMENT (B)

$60,096,875

Department of Health and Human Services·National Institutes of Health

to UNIVERSITY OF OKLAHOMA

biotechactiveONGOING · MOD OF 2013 CONTRACT

WORK BEGAN2013-09-01·LATEST ACTION2026-05-05·SOURCEUSASPENDING·SOURCE IDASST_NON_U54GM104938_075

Award description

OKLAHOMA SHARED CLINICAL AND TRANSLATIONAL RESOURCES

Verbatim from USAspending.gov. Capitalization, abbreviations, and codes are unchanged.

The Buildout's read

What the model surfaced from this award

Confidence: high

In plain English

Funds shared clinical and translational research resources at University of Oklahoma to advance biomedical discoveries from lab to patient care.

Sub-sectors

nih-research-grantsclinical-translational-researchacademic-research

Why this matters

Cooperative agreements like this accelerate the translation of basic research into clinical applications, strengthening U.S. biomedical innovation capacity.

Supply-chain signal

Supports demand for research equipment, reagents, and specialized services from biotech suppliers and contract research organizations.

U.S.–China competition angle

Invests in U.S. academic biomedical research infrastructure to maintain competitive advantage in translational medicine and drug development.

Generated by award_classification v2.0.0 via claude-haiku-4-5-20251001 on 2026-05-15. Cost: $0.002203.

Period of performance

Start

2013-09-01

End

2028-06-30

Status

activein 774 days

Recipient

UNIVERSITY OF OKLAHOMA

UEI GY8NMUZQXVS7

View full profile →

Other awards from this recipient

See all →

—OKLAHOMA IDEA NETWORK OF BIOMEDICAL RESEARCH EXCELLENCE$52.3M

Sources

USAspending.gov — all awards for this UEI →
SAM.gov entity registration →
Award record ingested from usaspending. Source identifier ASST_NON_U54GM104938_075.

The Buildout does not edit federal records. Any inaccuracy reflects the upstream source; it will update here when corrected there.